Cargando…

Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. To date, there is no effective treatment that halts its progression. Increasing evidence indicates that mitochondria play an important role in the development of PD. Hence mitochondria-targeted approaches or agents may ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Peizhong, Meshul, Charles K., Thuillier, Philippe, Reddy, P. Hemachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609669/ https://www.ncbi.nlm.nih.gov/pubmed/23543038 http://dx.doi.org/10.3390/ph6010108

Ejemplares similares

CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria
por: Mao, Peizhong, et al.
Publicado: (2012)

Potential Antidepressant Role of Neurotransmitter CART: Implications for Mental Disorders
por: Mao, Peizhong
Publicado: (2011)

Is multiple sclerosis a mitochondrial disease?
por: Mao, Peizhong, et al.
Publicado: (2010)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2006)

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
por: Reddy, Tejaswini P., et al.
Publicado: (2011)

Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015)

Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2011)

Therapeutics of Alzheimer’s Disease: Recent Developments
por: Burns, Scott, et al.
Publicado: (2022)

CART and PEV: New tools for Higgs searches
por: Ealet, A,, et al.
Publicado: (1998)

Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2022)

The neurobiology of impulse control disorders in Parkinson’s disease: from neurotransmitters to neural networks
por: Vriend, Chris
Publicado: (2018)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
por: Lian, Teng-hong, et al.
Publicado: (2020)

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
por: Kremer, Thomas, et al.
Publicado: (2021)

The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson’s disease
por: Alosaimi, Faisal, et al.
Publicado: (2022)

A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease
por: Chen, Xi, et al.
Publicado: (2023)

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
por: Gerlach, Manfred, et al.
Publicado: (2011)

Therapeutic value of the metabolomic active neurotransmitter isorhynchophylline in the treatment of spontaneously hypertensive rats by regulating neurotransmitters
por: Alharbi, Homood, et al.
Publicado: (2021)

Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes
por: Pan, Xiaohui, et al.
Publicado: (2022)

Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review
por: Jamwal, Sumit, et al.
Publicado: (2019)

Cartes postales électroniques
Publicado: (1987)

Evaluation of the New York City Green Carts program
por: Farley, Shannon M, et al.
Publicado: (2015)

CART Cell Toxicities: New Insight into Mechanisms and Management
por: Zahid, Anas, et al.
Publicado: (2020)

In vivo CART cell imaging: Paving the way for success in CART cell therapy
por: Sakemura, Reona, et al.
Publicado: (2021)

The apple cart : a political extravaganza /
por: Shaw, Bernard, 1856-1950
Publicado: (1932)

Neurophysiological assessment of juvenile parkinsonism due to primary monoamine neurotransmitter disorders
por: Passaretti, Massimiliano, et al.
Publicado: (2022)

Les dernières cartes : roman /
por: Schnitzler, Arthur, 1862-1931
Publicado: (1953)

The cart and the trumpet : the plays of George Bernard Shaw
por: Valency, Maurice
Publicado: (1973)

Trophoblast glycoprotein is a new candidate gene for Parkinson’s disease
por: Park, Sanghyun, et al.
Publicado: (2021)

Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters
por: Piao, Ying-Shan, et al.
Publicado: (2017)

Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson’s disease
por: Khan, Ahmed Faraz, et al.
Publicado: (2023)

Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy
por: Niello, Marco, et al.
Publicado: (2020)

CART cell therapy for prostate cancer: status and promise
por: Yu, Haiyuan, et al.
Publicado: (2019)

Jeu de cartes Orpheus ; Agon /
por: Stravinsky, Igor, 1882-1971
Publicado: (1994)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Oliver, Darryll, et al.
Publicado: (2019)

Age-Related Chronic Diseases and Alzheimer’s Disease in Texas: A Hispanic Focused Study
por: Sheladia, Shyam, et al.
Publicado: (2021)

Cartes de Carles Riba
Publicado: (1990)

The boy wit a cart/
por: Fry Christopher

CARTing Away Cardiac Fibrosis
por: Epstein, Jonathan A.
Publicado: (2020)

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation
por: Holland, Elizabeth M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_57bapc2fmnrg5r6002r5955jtu